Tulane University is actively seeking commercial entities to further develop and commercialize a novel method of treating infectious diseases using a combination of antibiotics and immunotherapeutics.
Treatment of bacterial infections with a combination of antibiotics and immunotherapeutics. Treatment of bacterial infections that are resistant to or failed to respond to antibiotic treatment. Flexible drug combinations and dosage regimens Demonstrated effectiveness at various stages of exposure and post-infection times. Applicable to a range of bacterial infectious diseases
This technology has been tested extensively in the laboratory and in mice with success at varying stages of exposure and post-infection times.